Abstract
Pioneer works have identified some microRNAs (miRNAs) with oncogenic or tumor-suppressive properties in glioblastoma multiforme (GBM), an aggressive brain tumor with dismal prognosis. Differential expression of these noncoding small RNA in cancers positions them as attractive biomarkers for diagnosis, prognosis and therapeutic decision in GBMs. In addition, abnormal miRNAs provide new interesting therapeutic targets for clinical GBM treatments despite the hurdles associated with such an approach. This review firstly summarizes abnormal expressed genes and upstream miRNAs in GBMs. Next, our focus will be towards the signature of miRNAs in GBM, and discuss the importance of circulating miRNAs for cancer diagnosis. Finally, we summarize present miRNA target therapeutic strategies, and discuss the deficiencies and challenges.
Keywords: Glioblastoma multiforme, microRNAs, therapeutic targets.
Current Signal Transduction Therapy
Title:Perspective of MiRNAs in Clinical Glioblastoma Research
Volume: 9 Issue: 1
Author(s): Chunming Xiu, Wenwen Qi, Yunbo Wang, Hongtao Zhang and Nan Chi
Affiliation:
Keywords: Glioblastoma multiforme, microRNAs, therapeutic targets.
Abstract: Pioneer works have identified some microRNAs (miRNAs) with oncogenic or tumor-suppressive properties in glioblastoma multiforme (GBM), an aggressive brain tumor with dismal prognosis. Differential expression of these noncoding small RNA in cancers positions them as attractive biomarkers for diagnosis, prognosis and therapeutic decision in GBMs. In addition, abnormal miRNAs provide new interesting therapeutic targets for clinical GBM treatments despite the hurdles associated with such an approach. This review firstly summarizes abnormal expressed genes and upstream miRNAs in GBMs. Next, our focus will be towards the signature of miRNAs in GBM, and discuss the importance of circulating miRNAs for cancer diagnosis. Finally, we summarize present miRNA target therapeutic strategies, and discuss the deficiencies and challenges.
Export Options
About this article
Cite this article as:
Xiu Chunming, Qi Wenwen, Wang Yunbo, Zhang Hongtao and Chi Nan, Perspective of MiRNAs in Clinical Glioblastoma Research, Current Signal Transduction Therapy 2014; 9 (1) . https://dx.doi.org/10.2174/1574362409666140724183754
DOI https://dx.doi.org/10.2174/1574362409666140724183754 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
Current Pharmaceutical Design The Use of Immortalized Cell Lines in GPCR Screening: The Good, Bad and Ugly.
Combinatorial Chemistry & High Throughput Screening Pharmacologic Evidence of Green Tea in Targeting Tyrosine Kinases
Current Reviews in Clinical and Experimental Pharmacology Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry A Nanostructured Silica-Lipid Hybrid to Facilitate Oral SN-38-based Chemotherapy
Drug Delivery Letters HR MAS MR Spectroscopy in Metabolic Characterization of Cancer
Current Topics in Medicinal Chemistry Ex Vivo Liver – Directed Gene Therapy for the Treatment of Metabolic Diseases: Advances in Hepatocyte Transplantation and Retroviral Vectors
Current Gene Therapy MiR-125b Inhibits Cell Proliferation and Induces Apoptosis in Human Colon Cancer SW480 Cells <i>via</i> Targeting STAT3
Recent Patents on Anti-Cancer Drug Discovery Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine
Current Topics in Medicinal Chemistry Human Microdialysis
Current Pharmaceutical Biotechnology Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer
Current Cancer Drug Targets Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
Current Medicinal Chemistry Cancer Drug Discovery Targeting Histone Methyltransferases: An Update
Current Medicinal Chemistry Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery
Current Drug Targets Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume II)
CNS & Neurological Disorders - Drug Targets Fetal Mesenchymal Stem Cells in Cancer Therapy
Current Stem Cell Research & Therapy The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Role of Protein Tyrosine Phosphatase in Regulation of Cell Signaling Cascades Affecting Tumor Cell Growth: A Future Perspective as Anti-Cancer Drug Target
Current Pharmaceutical Biotechnology Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma
Current Cancer Drug Targets New Technologies for Drug Delivery Across the Blood Brain Barrier
Current Pharmaceutical Design